UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility, reported London South East.

What Happened: This is the first company in the United Kingdom to be granted a Good Manufacturing Practice or GMP registration by the Medicines and Healthcare products Regulatory Agency to produce medical marijuana on UK soil.

The move follows seven harvests and extractions in 2022 and the facility's inspection by MHRA in the fourth quarter.

Why It Matters

Founded in 2018, the same year the UK legalized medical marijuana, Celadon Pharmaceuticals is positioned to take its fair share of a market projected to surpass £1bn by 2026, according to an analysis from …

Full story available on Benzinga.com